MWNA
GOSS icon

Marshall Wace North America’s Gossamer Bio GOSS Stock Holding History

Marshall Wace North America’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10.6M Hold
10,508
– – 0.05% 341
2021
Q2 		$6.83M Hold
10,508
– – 0.03% 463
2021
Q1 		$7.78M Sell
10,508
-188
-2% -$152K 0.03% 451
2020
Q4 		$8.27M Buy
10,696
+188
+2% +$148K 0.04% 422
2020
Q3 		$10.4M Buy
+10,508
New +$11.1M 0.07% 274
2019
Q3 		– Sell
-3,250
Closed -$5.77M – 1389
2019
Q2 		$5.77M Sell
3,250
-2,243
-41% -$3.43M 0.04% 331
2019
Q1 		$9.52M Buy
+5,493
New +$9.16M 0.07% 217

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marshall Wace North America's GOSS Position: Q3 2021 in Review

Marshall Wace North America held its Gossamer Bio (GOSS) position steady in Q3 2021 at 10,508 shares worth $10.6M. The position accounts for 0.05% of the portfolio, ranked #341.

Marshall Wace North America first reported a position in GOSS in Q1 2019 and has held it in 7 quarters since. 125 funds tracked by Wall St. Rank hold GOSS as of Q3 2021.

  • Marshall Wace North America held 10,508 shares of Gossamer Bio worth $10.6M as of Q3 2021.
  • Marshall Wace North America left its Gossamer Bio share count unchanged in Q3 2021.
  • Gossamer Bio made up 0.05% of Marshall Wace North America's portfolio in Q3 2021, its #341 holding.
  • Marshall Wace North America first reported a position in Gossamer Bio in Q1 2019 and has held it in 7 quarters since.
  • 125 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.